In a recent Media Lab workshop, a group of industry experts came together to discuss the importance of understanding the patient’s experience, covering everything from the power of patient insights and working with patient associations, to the role of data and technology innovation in diagnostics, treatment and prevention.

Stephen has spent the past 30+ years focused on communications for the healthcare sector – working with high profile pharmaceutical, biotech, medical device, health and wellbeing brands across many therapeutic areas.

A blended approach to home/office working is expected in 2021, but in this industry office work remains crucial to ensure the flow of creative ideas and team building/trust.

What are some of the biggest miscommunications P&P have noticed during the pandemic?

Miscommunication, confusion and (dare I say it?) fake news. These are certainly not the words you want associated with a life-saving inoculation; and yet, communication surrounding the COVID-19 vaccine has been rife with perplexities. 

Humans are diverse and communications to engage us need to be inclusive. It’s no longer about talking to a group, a cohort or an imagined section of society – especially in healthcare.

The landscape of our healthcare system is ever evolving. But it is under threat from the diminishing time allowances our healthcare professionals (HCPs) have to spend with each patient.

The COVID-19 pandemic has brought into sharp focus the need to harness and leverage digital tools and technology for remote patient monitoring (RPM).

As the pharma industry seeks to bring the patient ever closer to the centre of what is becoming an increasingly collaborative drug development process, it is increasingly turning to social media to glean and disseminate information.